Real-time enrollment status for this pkp2 arrhythmogenic cardiomyopathy (pkp2-acm) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:53 AM UTC
| NCT Number | NCT05885412 |
| Recruiting Status | Recruiting |
| Condition | PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) |
| Phase | Clinical Trial |
| Target Enrollment | 9 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Rocket Pharmaceuticals Inc. |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 13, 2026: Clinical trial NCT05885412 is currently recruiting participants. This clinical trial study for pkp2 arrhythmogenic cardiomyopathy (pkp2-acm) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Rocket Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05885412 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05885412 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.